^
    over3years
    Phase 1 Study of BPI-442096 in Advanced Solid Tumor Patients (clinicaltrials.gov)
    P1, N=230, Not yet recruiting, Betta Pharmaceuticals Co., Ltd.
    New P1 trial
    |
    KRAS (KRAS proto-oncogene GTPase) • BRAF (B-raf proto-oncogene) • NF1 (Neurofibromin 1)
    |
    KRAS mutation • BRAF mutation • NF1 mutation • KRAS G12
    |
    BPI-442096